This job is no longer taking applications and is displayed only for reference.
To view current postings please conduct a new search.
Thank you.
The University of Saskatchewan invites applications from outstanding scholars for the Saskatchewan-GlaxoSmithKline Research Chair in Rational Drug Design.
The successful candidate will have a PhD in Pharmaceutical Sciences or a closely-related discipline and postdoctoral experience. He or she has strong a track record in research and experience in interdisciplinary research partnerships. Appropriate areas of drug discovery and development research include: pharmacokinetics and dynamics, drug design and medicinal chemistry, analytical chemistry and drug metabolism or a related field bridging the chemical and life sciences.
The appointed Saskatchewan-GSK Research Chair in Rational Drug Design is expected to promote and advance collaborative research programs, provide leadership, and help strengthen drug discovery and development research in Saskatchewan. The incumbent will collaborate with fellow researchers of the University of Saskatchewans Drug Discovery and Development Research Group, which provides pharmaceutical, nutritional, and molecular sciences expertise with an aim to develop effective and sustainable therapeutic strategies for the prevention and treatment of disease.
The successful candidate will be appointed to a tenure-track position in the College of Pharmacy and Nutrition at an academic rank commensurate with experience. Salary bands for this post are as follows: Assistant Professor $86,844 $104,357; Associate Professor $104,357 - $121,871 and Professor $121,871 - $142,303. This position comes with a comprehensive benefits package which includes pension plan, life insurance (compulsory and voluntary), academic long-term disability, sick leave, travel insurance, death benefit, dental plan, extended health and vision care plan, employee assistance program and flexible health and wellness spending program.
The competition is currently open; applications will be reviewed beginning May 15th, 2015 and will remain open until filled.